閉塞性睡眠時無呼吸症および肥満または過体重の患者におけるオルフォルグリプロンのマスタープロトコル

基本情報

NCT ID

NCT06649045

ステータス

実施中（募集終了）

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

600

治験依頼者名

Eli Lilly and Company

概要

Study GZRA is a master protocol that will support 2 independent studies, GZ01 and GZ02. Participants will be assigned to the appropriate study prior to randomization. The purpose of the studies is to evaluate the efficacy and safety of orforglipron in participants who have moderate-to-severe OSA and obesity or overweight. Study GZ01 will include participants who are unable or are unwilling to use PAP therapy. Study GZ02 will include participants who are on PAP therapy for at least 3 months at time of screening and plan to continue PAP therapy during the study.

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)